Market revenue in 2023 | USD 127.5 million |
Market revenue in 2030 | USD 226.6 million |
Growth rate | 8.6% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceutical industry |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
Pharmaceutical industry was the largest segment with a revenue share of 43.29% in 2023. Horizon Databook has segmented the UAE in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
The in-vitro toxicology testing market in UAE is witnessing increasing competition due to the growth of the pharmaceutical industry and increasing awareness about the importance of preclinical testing. UAE has a growing number of pharmaceutical companies, both local and international, which are driving demand for in vitro toxicology testing services.
Moreover, there is increasing government support for the development of the pharmaceutical industry in the region, which is further boosting the demand for in vitro toxicology testing.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account